BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 30771520)

  • 1. Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors.
    Robelin P; Hadoux J; Forestier J; Planchard D; Hervieu V; Berdelou A; Scoazec JY; Valette PJ; Leboulleux S; Ducreux M; Lombard-Bohas C; Baudin E; Walter T
    J Thorac Oncol; 2019 Jun; 14(6):993-1002. PubMed ID: 30771520
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pulmonary carcinoid: analysis of a single institutional experience and prognostic factors].
    Correia Sda S; Pinto C; Bernardo J
    Acta Med Port; 2014; 27(6):749-54. PubMed ID: 25641291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.
    Caplin ME; Baudin E; Ferolla P; Filosso P; Garcia-Yuste M; Lim E; Oberg K; Pelosi G; Perren A; Rossi RE; Travis WD;
    Ann Oncol; 2015 Aug; 26(8):1604-20. PubMed ID: 25646366
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of chromogranin A levels and somatostatin receptor scintigraphy findings in the evaluation of metastases in carcinoid tumors.
    Namwongprom S; Wong FC; Tateishi U; Kim EE; Boonyaprapa S
    Ann Nucl Med; 2008 May; 22(4):237-43. PubMed ID: 18535873
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome Analysis of First-line Somatostatin Analog Treatment in Metastatic Pulmonary Neuroendocrine Tumors and Prognostic Significance of
    Bongiovanni A; Recine F; Riva N; Foca F; Liverani C; Mercatali L; Nicolini S; Pieri F; Amadori D; Ibrahim T
    Clin Lung Cancer; 2017 Jul; 18(4):415-420. PubMed ID: 27956089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Natural History of Localized and Locally Advanced Atypical Lung Carcinoids after Complete Resection: A Joined French-Italian Retrospective Multicenter Study.
    Marciello F; Mercier O; Ferolla P; Scoazec JY; Filosso PL; Chapelier A; Guggino G; Monaco R; Grimaldi F; Pizzolitto S; Guigay J; de Latour BR; Giuffrida D; Longchampt E; de Montpreville VT; Fadel E; Colao A; Planchard D; Papotti M; Faggiano A; Baudin E
    Neuroendocrinology; 2018; 106(3):264-273. PubMed ID: 28813709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis, treatment, and prognosis of bronchopulmonary carcinoid: an analysis of 74 patients.
    Chi Y; Gao S; Du F; Wang JW; Jiang WC; Sun YK; Song Y; He J
    Anticancer Drugs; 2016 Jan; 27(1):54-9. PubMed ID: 26398932
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnosis and management of typical and atypical lung carcinoids.
    Pusceddu S; Lo Russo G; Macerelli M; Proto C; Vitali M; Signorelli D; Ganzinelli M; Scanagatta P; Duranti L; Trama A; Buzzoni R; Pelosi G; Pastorino U; de Braud F; Garassino MC
    Crit Rev Oncol Hematol; 2016 Apr; 100():167-76. PubMed ID: 26917456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. 68Gallium DOTANOC-PET Imaging in Lung Carcinoids: Impact on Patients' Management.
    Lamarca A; Pritchard DM; Westwood T; Papaxoinis G; Nonaka D; Vinjamuri S; Valle JW; Manoharan P; Mansoor W
    Neuroendocrinology; 2018; 106(2):128-138. PubMed ID: 28399530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Pulmonary neuroendocrine tumors. The spectrum of histologic subtypes and current concept on diagnosis and treatment].
    Langfort R; Rudziński P; Burakowska B
    Pneumonol Alergol Pol; 2010; 78(1):33-46. PubMed ID: 20162517
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current diagnosis and treatment of gastrointestinal carcinoids in a series of 101 patients: the significance of serum chromogranin-A, somatostatin receptor scintigraphy and somatostatin analogues.
    Nikou GC; Lygidakis NJ; Toubanakis C; Pavlatos S; Tseleni-Balafouta S; Giannatou E; Mallas E; Safioleas M
    Hepatogastroenterology; 2005; 52(63):731-41. PubMed ID: 15966194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy for locally advanced and metastatic pulmonary carcinoid tumors.
    Chong CR; Wirth LJ; Nishino M; Chen AB; Sholl LM; Kulke MH; McNamee CJ; Jänne PA; Johnson BE
    Lung Cancer; 2014 Nov; 86(2):241-6. PubMed ID: 25218177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical management of atypical carcinoid and large-cell neuroendocrine carcinoma: a multicentre study on behalf of the European Association of Thoracic Surgeons (ESTS) Neuroendocrine Tumours of the Lung Working Group†.
    Filosso PL; Rena O; Guerrera F; Moreno Casado P; Sagan D; Raveglia F; Brunelli A; Welter S; Gust L; Pompili C; Casadio C; Bora G; Alvarez A; Zaluska W; Baisi A; Roesel C; Thomas PA;
    Eur J Cardiothorac Surg; 2015 Jul; 48(1):55-64. PubMed ID: 25406425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of the combination of oxaliplatin and 5-fluorouracil or gemcitabine in patients with sporadic metastatic pulmonary carcinoid tumors.
    Walter T; Planchard D; Bouledrak K; Scoazec JY; Souquet PJ; Dussol AS; Guigay J; Hervieu V; Berdelou A; Ducreux M; Arpin D; Lombard-Bohas C; Baudin E
    Lung Cancer; 2016 Jun; 96():68-73. PubMed ID: 27133753
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical analysis of 17 cases of lung carcinoid tumor].
    Kong L; Wang Z; Wang R; Zhao X; Li B; Zhou T
    Zhonghua Jie He He Hu Xi Za Zhi; 2002 May; 25(5):265-7. PubMed ID: 12133316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuroendocrine tumors of the bronchopulmonary system (typical and atypical carcinoid tumors): current strategies in diagnosis and treatment. Conclusions of an expert meeting February 2011 in Weimar, Germany.
    Hörsch D; Schmid KW; Anlauf M; Darwiche K; Denecke T; Baum RP; Spitzweg C; Grohé C; Presselt N; Stremmel C; Heigener DF; Serke M; Kegel T; Pavel M; Waller CF; Deppermann KM; Arnold R; Huber RM; Weber MM; Hoffmann H
    Oncol Res Treat; 2014; 37(5):266-76. PubMed ID: 24853787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of carcinoid of the lung.
    Kosmidis PA
    Curr Opin Oncol; 2004 Mar; 16(2):146-9. PubMed ID: 15075907
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatic arterial embolization and chemoembolization for the treatment of patients with metastatic neuroendocrine tumors: variables affecting response rates and survival.
    Gupta S; Johnson MM; Murthy R; Ahrar K; Wallace MJ; Madoff DC; McRae SE; Hicks ME; Rao S; Vauthey JN; Ajani JA; Yao JC
    Cancer; 2005 Oct; 104(8):1590-602. PubMed ID: 16134179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Cancers-Specific Survival of Metastatic Pulmonary Carcinoids and Sites of Distant Metastasis: A Population-Based Study.
    Zhang J; Yu Q; He Y; Hu T; Chen K; Yang Z; Zhang X; Cheng D; He Z
    Technol Cancer Res Treat; 2021; 20():15330338211036528. PubMed ID: 34378452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Bronchopulmonary carcinoid tumours].
    Rena O; Filosso PL; Ruffini E; Oliaro A
    Minerva Chir; 2002 Aug; 57(4):403-23. PubMed ID: 12145571
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.